Graft aberrant hepatic arteries in deceased donor liver transplantation: The "one liver, one artery" approach.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
12 2022
Historique:
revised: 16 05 2022
received: 24 01 2022
accepted: 07 06 2022
pubmed: 26 6 2022
medline: 16 11 2022
entrez: 25 6 2022
Statut: ppublish

Résumé

In liver transplantation (LT), graft aberrant hepatic arteries (aHAs) frequently require complex arterial reconstructions, potentially increasing the risk of post-operative complications. However, intrahepatic hilar arterial shunts are physiologically present and may allow selective aHA ligation. Thus, we performed a retrospective study from a single-center cohort of 618 deceased donor LTs where a selective reconstruction policy of aHAs was prospectively applied. In the presence of any aHA, the vessel with the largest caliber was first reconstructed. In case of adequate bilobar arterial perfusion assessed on intraparenchymal Doppler ultrasound, the remnant vessel was ligated; otherwise, it was reconstructed. Consequently, outcomes of three patient groups were compared: the "no aHAs" group (n = 499), the "reconstructed aHA" group (n = 25), and the "ligated aHA" group (n = 94). Primary endpoint was rate of biliary complications. Only 38.4% of right aHAs and 3.1% of left aHAs were reconstructed. Rates of biliary complications in the no aHA, reconstructed aHA, and ligated aHA groups were 23.4%, 28%, and 20.2% (p = 0.667), respectively. The prevalence rates of primary non-function (p = 0.534), early allograft dysfunction (p = 0.832), and arterial complications (p = 0.271), as well as patient survival (p = 0.266) were comparable among the three groups. Retransplantation rates were 3.8%, 4%, and 5.3% (p = 0.685), respectively. In conclusion, a selective reconstruction policy of aHAs based on Doppler assessment of bilobar intraparenchymal arterial flow did not increase post-operative morbidity and avoided unnecessary and complex arterial reconstructions.

Identifiants

pubmed: 35751148
doi: 10.1002/lt.26536
pii: 01445473-202212000-00013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1876-1887

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 American Association for the Study of Liver Diseases.

Références

Karakoyun R, Romano A, Yao M, Dlugosz R, Ericzon BG, Nowak G. Impact of hepatic artery variations and reconstructions on the outcome of orthotopic liver transplantation. World J Surg. 2020;44:1954–65.
Montalti R, Benedetti Cacciaguerra A, Nicolini D, Ahmed EA, Coletta M, De Pietri L, et al. Impact of aberrant left hepatic artery ligation on the outcome of liver transplantation. Liver Transpl. 2018;24:204–13.
Herrero A, Souche R, Joly E, Boisset G, Habibeh H, Bouyabrine H, et al. Early hepatic artery thrombosis after liver transplantation: what is the impact of the arterial reconstruction type? World J Surg. 2017;41:2101–10.
Teegen EM, Globke B, Denecke T, Pascher A, Öllinger R, Pratschke J, et al. Vascular anomalies of the extrahepatic artery as a predictable risk factor for complications after liver transplant. Exp Clin Transplant. 2019;17:522–8.
Pérez‐Saborido B, Pacheco‐Sánchez D, Barrera Rebollo A, Fuentes PP, Díaz EA, Rodriguez FL, et al. Incidence of hepatic artery variations in liver transplantation: does it really influence short‐ and long‐term results? Transplant Proc. 2012;44:2606–8.
Uchiyama H, Harada N, Sanefuji K, Kayashima H, Taketomi A, Soejima Y, et al. Dual hepatic artery reconstruction in living donor liver transplantation using a left hepatic graft with 2 hepatic arterial stumps. Surgery. 2010;147:878–86.
Uchiyama H, Yoshizumi T, Ikegami T, Harimoto N, Itoh S, Okabe H, et al. The use of left grafts with a replaced or accessory left hepatic artery in adult‐to‐adult living donor liver transplantation: analyses of donor and recipient outcomes. Clin Transplant. 2016;30:1021–7.
Marcos A, Orloff M, Mieles L, Olzinski A, Sitzmann J. Reconstruction of double hepatic arterial and portal venous branches for right‐lobe living donor liver transplantation. Liver Transpl. 2001;7:673–9.
Imamura H, Makuuchi M, Sakamoto Y, Sugawara Y, Sano K, Nakayama A, et al. Anatomical keys and pitfalls in living donor liver transplantation. J Hepatobiliary Pancreat Surg. 2000;7:380–94.
Sugawara Y, Tamura S, Kaneko J, Iida T, Mihara M, Makuuchi M, et al. Single artery reconstruction in left liver transplantation. Surgery. 2011;149:841–5.
Kishi Y, Sugawara Y, Kaneko J, Akamatsu N, Imamura H, Asato H, et al. Hepatic arterial anatomy for right liver procurement from living donors. Liver Transpl. 2004;10:129–33.
Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg. 1966;112:337–47.
Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680–8.
Magro B, Tacelli M, Mazzola A, Conti F, Celsa C. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr. 2021;10:76–92.
Uemura T, Randall HB, Sanchez EQ, Ikegami T, Narasimhan G, McKenna GJ, et al. Liver retransplantation for primary nonfunction: analysis of a 20‐year single‐center experience. Liver Transpl. 2007;13:227–33.
Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16:943–9.
Sarwar A, Chen C, Khwaja K, Malik R, Raven KE, Weinstein JL, et al. Primary stent placement for hepatic artery stenosis after liver transplantation: improving primary patency and reintervention rates. Liver Transpl. 2018;24:1377–83.
Mourad MM, Algarni A, Liossis C, Bramhall SR. Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol. 2014;20:6159–69.
Gastaca M, Matarranz A, Martinez L, Valdivieso A, Ruiz P, Ventoso A, et al. Risk factors for biliary complications after orthotopic liver transplantation with T‐tube: a single‐center cohort of 743 transplants. Transplant Proc. 2014;46:3097–9.
Abouljoud MS, Kim DY, Yoshida A, Arenas J, Jerius J, Malinzak L, et al. Impact of aberrant arterial anatomy and location of anastomosis on technical outcomes after liver transplantation. J Gastrointest Surg. 2005;9:672–8.
Ferraz‐Neto BH, Meira‐Filho SR, Hidalgo R, Rezende MB, Zurstrassen MP, Thomé T, et al. Correlation between graft arterial anatomy and biliary complications after liver transplantation. Transplant Proc. 2007;39:2514–5.
Kubota K, Makuuchi M, Takayama T, Harihara Y, Hasegawa K, Aoki T, et al. Simple test on the back table for justifying single hepatic‐arterial reconstruction in living related liver transplantation. Transplantation. 2000;70:696–7.
Kim SH, Na BG, Lee EC, Park SJ. Arterial blood gas test to decide whether to reconstruct single or both the arteries in living donor liver transplantation. Hepatobiliary Surg Nutr. 2018;7:440–2.
Yanaga K, Tzakis AG, Starzl TE. Partial dearterialization of the liver allograft. Transpl Int. 1990;3:185–8.
Ang RRG, Lee HJ, Bae JS, Zhu CC, Berlth F, Kim TH, et al. Safety of ligation of aberrant left hepatic artery originating from left gastric artery in laparoscopic gastrectomy for gastric cancer. Sci Rep. 2020;10:5856.
Cirocchi R, D'Andrea V, Amato B, Renzi C, Henry BM, Tomaszewski KA, et al. Aberrant left hepatic arteries arising from left gastric arteries and their clinical importance. Surgeon. 2020;18:100–12.
Muller X, Marcon F, Sapisochin G, Marquez M, Dondero F, Rayar M, et al. Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results. Ann Surg. 2018;267:419–25.
Torzilli G, McCormack L, Pawlik T. Parenchyma‐sparing liver resections. Int J Surg. 2020;82S:192–7.
Donadon M, Torzilli G. Intraoperative ultrasound in patients with hepatocellular carcinoma: from daily practice to future trends. Liver Cancer. 2013;2:16–24.
Ferrero A, Lo Tesoriere R, Russolillo N. Ultrasound liver map technique for laparoscopic liver resections. World J Surg. 2019;43:2607–11.

Auteurs

Riccardo Pravisani (R)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.
Liver-Kidney Transplant Unit, Department of MedicineUniversity of UdineUdineItaly.

Ailton Sepulveda (A)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Lorenzo Cocchi (L)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Estrella de Mello (E)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Francois Cauchy (F)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Safi Dokmak (S)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Olivier Farges (O)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Francois Durand (F)

Hepatology and Liver Intensive Care, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Emmanuel Weiss (E)

Department of Anesthesiology and Critical Care, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Federica Dondero (F)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Mickaël Lesurtel (M)

Department of HPB Surgery and Liver Transplantation, AP-HP Beaujon HospitalUniversity of ParisClichyFrance.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH